Svetlana Pavlova

Prof. Svetlana Pavlova

Chuvash State University, Cheboksary, Chuvashiya, Russia
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in Microbiology and Immunology
Verified
Journal Article
Open access
PDF file
EKEkaterina V. Khokhlova
Ekaterina V. Khokhlova
VSVladimir V. Smeianov
Vladimir V. Smeianov
BEBoris A. Efimov
Boris A. Efimov
LKLyudmila I. Kafarskaia
Lyudmila I. Kafarskaia
SPSvetlana Pavlova
Svetlana Pavlova
ASAndrey N Shkoporov
Andrey N Shkoporov
Certain Bifidobacterium strains have been shown to inhibit inflammatory responses in intestinal epithelial cells. However, the precise mechanisms of these effects, including the chemical nature of the active compounds, remain to be elucidated. Here partial characterization of the anti‐inflammatory properties of Bifidobacterium strains isolated from feces of healthy infants is reported. It was found that conditioned media (CM) of all strains studied are capable of attenuating tumor necrosis factor‐α (TNF‐α) and lipopolysaccharide‐ (LPS) induced inflammatory responses in the HT‐29 cell line. In contrast, neither killed bifidobacterial cells, nor cell‐free extracts showed such activities. Further investigations resulted in attribution of this activity to heat‐stable, non‐lipophilic compound(s) resistant to protease and nuclease treatments and of molecular weight less than 3 kDa. The anti‐inflammatory effects were dose‐ and time‐dependent and associated with inhibition of IκB phosphorylation and nuclear factor‐κ light chain enhancer of activated B cells (NF‐κB)‐dependent promoter activation. The combined treatments of cells with CMs and either LPS or TNF‐α, but not with CMs alone, resulted in upregulation of transforming growth factor‐β1, IκBζ, and p21CIP mRNAs. Our data suggest certain species‐specificities of the anti‐inflammatory properties of bifidobacteria. This observation should prompt additional validation studies using larger set of strains and employing the tools of comparative genomics.

27 October 2022 in Membranes
Verified
Journal Article
Open access
PDF file
AZArina Zgodova
Arina Zgodova
SPSvetlana Pavlova
Svetlana Pavlova
ANAnastasia Nekrasova
Anastasia Nekrasova
DBDmitry Boyarkin
Dmitry Boyarkin
V. G. PinelisV. G. Pinelis
V. G. Pinelis
Zanda BakaevaZanda Bakaeva
Zanda Bakaeva
It is considered that glutamate excitotoxicity may be a major factor in the pathological death of neurons and mediate the development of neurodegenerative diseases in humans. Here, we show that isoliquiritigenin (ILG) at a concentration of 0.5–5 µM protects primary neuroglial cell culture from glutamate-induced death (glutamate 100 µM). ILG (1 µM) prevented a sharp increase in [Ca2+]i and a decrease in mitochondrial potential (ΔΨm). With the background action of ILG (1–5 µM), there was an increase in oxygen consumption rate (OCR) in response to glutamate, as well as in reserve respiration. The neuroprotective effect of ILG (5 µM) was accompanied by an increase in non-mitochondrial respiration. The results show that ILG can protect cortical neurons from death by preventing the development of calcium deregulation and limiting mitochondrial dysfunction caused by a high dose of glutamate. We hypothesize that ILG will be useful in drug development for the prevention or treatment of neurodegenerative diseases accompanied by glutamate excitotoxicity.

1 June 2003 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
SPSvetlana Pavlova
Svetlana Pavlova
BUB. S. Uteshev
B. S. Uteshev
ASA. V. Sergeev
A. V. Sergeev

1 January 2016 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
SPSvetlana Pavlova
Svetlana Pavlova
DAD. Z. Albegova
D. Z. Albegova
YVYu. S. Vorob’eVa
Yu. S. Vorob’eVa
OLO. S. Laptev
O. S. Laptev
IKI. G. Kozlov
I. G. Kozlov

1 January 2024 in Problems of Nutrition
Verified
Journal Article
Open access
SPSvetlana Pavlova
Svetlana Pavlova
Роль микробиоты и флавоноидов в поддержании баланса хелперных и регуляторных Т-лимфоцитов, ассоциированных с иммунным барьером кишечника

1 September 2015 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
DAD. Z. Albegova
D. Z. Albegova
OKO. V. Kamkina
O. V. Kamkina
SPSvetlana Pavlova
Svetlana Pavlova
ZAZh. K. Albegova
Zh. K. Albegova
OLO. S. Laptev
O. S. Laptev
IKI. G. Kozlov
I. G. Kozlov